Navigation Links
Proposed CMS Changes Related to Consultant Pharmacists Raise Profound Concerns for Pharmacies
Date:11/2/2011

WASHINGTON, Nov. 2, 2011 /PRNewswire-USNewswire/ -- The Long Term Care Pharmacy Alliance (LTCPA) is carefully reviewing a recent proposal by the Centers for Medicare and Medicaid Services (CMS) regarding potential changes to the independence of consultant pharmacists as a consideration of the Conditions of Participation for Long Term Care Facilities in the Medicare program.

Our member companies and individual pharmacists have expressed sincere concern with CMS' apparent failure to recognize long-term care pharmacies' and pharmacists' role in providing appropriate, patient-centered, cost-effective care to nursing home residents in its Guidance. In fact, CMS made numerous negative inferences in its Guidance concerning LTC pharmacies and pharmacists' behavior without the presentation of any data to substantiate these inferences or claims.

LTCPA was disappointed that the proposal from CMS noted without sufficient explanation that long term care pharmacies' costs exceed those of retail. It has been well documented and broadly understood that prescription costs in long term care are legitimately higher than retail due to the unique elderly population as well as specialized packaging, 24 hour service and multiple daily deliveries.  

In order to address the legitimate concerns raised by CMS regarding the role of consulting pharmacists in the long–term care setting, LTCPA supports an evidence-based review of trends in prescription drug utilization and therapeutic interchange among states that require a separate business relationship between the consultant pharmacist and pharmacy provider and those states that do not.

LTCPA looks forward to working with CMS to analyze the implications of these proposed changes to patients and providers of long term care and remains committed to informing policy makers about the important role that long term care pharmacies play in ensuring the safe and efficient distribution of medication to nursing home residents.

About LTCPA
LTCPA membership is comprised of two national chain-based LTC pharmacy providers, Omnicare and PharMerica, in addition to approximately 900 independent LTC pharmacies that together serve 1.8 million Medicare Part D beneficiaries, or ninety percent of all LTC facility residents.


'/>"/>
SOURCE Long Term Care Pharmacy Alliance (LTCPA)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cempra Holdings, LLC Files Registration Statement for Proposed Initial Public Offering
2. McDonald Hopkins Applauds Bipartisan Effort to Halt Proposed Regulation that will Hurt Pharmacies and Physicians
3. European Fine Chemicals Group Ratifies FDAs Proposed Generic Drug User Fees Act (GDUFA)
4. IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients
5. FDA Seeks Comment on Proposed Guidelines for High-Quality Clinical Studies
6. Argos Therapeutics Files Registration Statement for Proposed Initial Public Offering
7. Accuray Announces Proposed Offering of $75 Million Convertible Senior Notes
8. NeoStem Announces Proposed Public Offering of Common Stock
9. Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes
10. Rigel Announces Proposed Public Offering of Common Stock
11. CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... The Institute for In Vitro Sciences (IIVS), ... of a VITROCELL® inhalation exposure system thanks to a ... device, which is designed to replace animals in inhalation ... to airborne test materials in an environment that mimics ... for testing combustible tobacco products, as well as next ...
Breaking Medicine Technology:
(Date:7/23/2017)... , ... July 23, 2017 , ... ... announce today the grant of US Patent No. 9,038,640 by the United States ... technology and brings together the combination of Switching, Vacuum, and Cooling mechanisms to ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... services to families and business owners in the Dalton region, is working in ... children overcoming sexual assault and physical abuse. , The GreenHouse is headquartered in ...
(Date:7/21/2017)... ... July 21, 2017 , ... Adolfson ... renovate and improve the Ramsey County Medical Examiners Facility located in Saint Paul, ... $2.5 million project is scheduled to start in late 2017/early 2018. , ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... The Margarian ... falsely advertising the contents of its ginger ale for allegedly containing no ginger. Dr. ... Dr. Pepper Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® Water ... population and the greatest number of sufferers of blindness. “We think that Nature’s ...
Breaking Medicine News(10 mins):